Wells Fargo analyst Brandon Couillard maintained a Hold rating on Danaher (DHR – Research Report) today and set a price target of $240.00. The ...

Investors with a lot of money to spend have taken a bullish stance on Danaher DHR. And retail traders should know. We noticed this today when the positions showed up on publicly available options ...

In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other best cancer stocks to buy. Cancer is the second leading cause of death across the globe ...

Shares of Danaher Corp. DHR shed 3.81% to $214.26 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.76% to 5,994.57 and Dow ...

KKR builds stake in Henry Schein, reaches deal to add board seats Danaher on Wednesday missed Wall Street estimates for fourth-quarter profit due to soft demand for tools and services used in drug ...

Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the fourth quarter and full year 2024. All results in this release reflect only continuing operations unless otherwise ...

Through its Danaher Business System, Danaher aims for continuous improvement of its scientific technology portfolio by seeking out attractive markets and then making acquisitions to enter or ...

(RTTNews) - Danaher Corporation (DHR) said, for the first quarter 2025, the company anticipates that non-GAAP core revenue will decline low-single digits year-over-year. For full year 2025 ...

WASHINGTON (AP) — WASHINGTON (AP) — Danaher Corp. (DHR) on Wednesday reported fourth-quarter net income of $1.09 billion. The Washington-based company said it had profit of $1.49 per share.